At the Cybersecurity Frontier: Key Strategies and Persistent Challenges for Business Leaders
Strategic Change · 2025-03 · 34 (2) · 181-192
DOI: 10.1002/jsc.2622 ↗Kurz gefasst
Fachartikel in der Zeitschrift Strategic Change, online erschienen am 17.12.2024. Verfasst von Marco Balzano und 1 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study disentangles the cybersecurity landscape, highlighting its strategic role in contemporary digital environments. Aligned with modern holistic management approaches, it uncovers key insights and strategic imperatives by distilling core lessons and identifying ongoing challenges in the field. We emphasize significant contributions to understanding enduring lessons and addressing unresolved challenges in cybersecurity literature. The findings underscore the relevance of adopting a strategic approach to cybersecurity, one that balances technological solutions with human behavior, training, and awareness. Additionally, the study examines the evolving nature of cyber threats, the impact of legal and regulatory frameworks, and ethical dilemmas, emphasizing the need for continuous adaptation and proactive management in the face of increasingly sophisticated digital risks.
Zitieren
APA
Balzano, M., & Marzi, G. (2025). At the Cybersecurity Frontier: Key Strategies and Persistent Challenges for Business Leaders. Strategic Change, 34(2), 181-192. https://doi.org/10.1002/jsc.2622
Vancouver
Balzano M, Marzi G. At the Cybersecurity Frontier: Key Strategies and Persistent Challenges for Business Leaders. Strategic Change. 2025;34(2):181-192. doi:10.1002/jsc.2622
BibTeX
@article{Balzano2025,
author = {Balzano, Marco and Marzi, Giacomo},
title = {At the Cybersecurity Frontier: Key Strategies and Persistent Challenges for Business Leaders},
journal = {Strategic Change},
year = {2025},
volume = {34},
number = {2},
pages = {181--192},
doi = {10.1002/jsc.2622}
}
EUVIMED